J&J (JNJ) Guides FY13 Reported Revs Below Consensus
Johnson & Johnson (NYSE: JNJ) sees FY13 reported revs of $70.9 billion to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
